9530 Padgett Street
San Diego, CA 92126
866 290 2157
Full-time employees: 42
|Mr. Joseph D. Dowling||CEO, Sec. & Director||298.98k||N/A||1957|
|Mr. Joerg Grasser||Chief Financial Officer||210.47k||N/A||1975|
|Mr. Tim Hitchman||VP of Operations||N/A||N/A||N/A|
|Mr. Stuart Tomc||Sr. VP of Human Nutrition||N/A||N/A||N/A|
|Mr. Jesse Karagianes||Sr. VP of Revenue Growth||N/A||N/A||N/A|
|Ms. Alyssa Dunn||Operations Mang.||N/A||N/A||N/A|
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
CV Sciences, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.